| 2929.10.80 | 10 | Methylenedi-p-phenylene isocyanate (MDI) | kg | | | |
| 2929.90.05 | 00 | 2,2'-Bis(4-cyanatophenyl)-1,1,1,3,3,3-hexafluoro- propane; 2,2-Bis((4-cyanatophenyl)propane; 1,1-Ethylidenebis(phenyl-4-cyanate); 4,4'-Methylenebis(2,6-dimethylphenylcyanate); and 1,3-Phenylenebis((1-methylethylidenebis)cyanic acid, 1,4-phenylene ester | kg | Free | | 15.4¡é/kg + 52% |
| 2930.90.26 | 00 | 3-(4'-Aminobenzamido)phenyl-¡é/hydroxy- ethylsulfone; 2-[(4-Aminophenyl)sulfonyl]ethanol, hydrogen sulfate ester; Diphenylthiourea; N,N'-(Dithiodi-2,1-phenylene)bisbenzamide; Pentachlorothiophenol; and 4,4'-Thiodiphenyl cyanate | kg | Free | | 15.4¡é/kg + 40.5% |
| 2930.90.30 | 00 | Thiocyanates, thiurams and isothiocyanates | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 25% |
| 2930.90.43 | 10 | O-Ethyl-S-phenylethylphosphono- thiolothionate (fonofos) | kg | | | |
| 2930.90.91 | 07 | O,O-Diethyl S-[2-(diethylamino)- ethyl]phosphorothioate and its alkylated or protonated salts; and Thiodiglycol (INN) (bis(2-hydroxy- ethyl) sulfide) | kg | | | |
| 2930.90.91 | 23 | N,N-Dialkyl (methyl, ethyl, n-propyl or isopropyl)aminoethane-2-thiols and their protonated salts | kg | | | |
| 2932.11.00 | 00 | Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure: | | | | |
| 2932.99.08 | 00 | 2-Ethoxy-2,3-dihydro-3,3-dimethyl-5- benzofuranylmethanesulfonate | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 40.5% |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¡é/kg + 46% |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 2936.90.01 | | Other, including proviatmins and natural concentrates | | Free | | 25% |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.22.00 | 00 | Halogenated derivatives of adrenal cortical hormones | g | Free | | 25% |
| 2937.23.25 | 00 | Estradiol benzoate; and Estradiol cyclopentylpropionate (Estradiol cypionate) | g | Free | | 15.4¡é/kg + 49% |
| 2937.29.10 | 00 | Desonide; and Nandrolone phenproprionate | g | Free | | 15.4¡é/kg + 49% |
